Page 2 - அன்னே பீல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அன்னே பீல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அன்னே பீல் Today - Breaking & Trending Today

Investegate |GlaxoSmithKline PLC Announcements | GlaxoSmithKline PLC: Board and Committee Changes


A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

Emma Walmsley , Jesse Goodman , Charles Bancroft , Vivienne Cox , Laurie Glimcher , Anne Beal , Lynn Elsenhans , Vindi Banga , Iain Mackay , Jonathan Symonds , Hal Barron , Urs Rohner , Audit Risk Committee , Corporate Responsibility Committee , Transformation Separation Committee , Independent Non Executive , Corporate Responsibility , Corporate Governance , Risk Committee , Scientific Officer , எம்மா வால்ம்ஸ்லி , ஜெஸ்ஸி நல்ல மனிதன் , சார்லஸ் பான்கிராப்ட் , அன்னே பீல் , இயேந் மகே , ஜொனாதன் சைமண்ட்ஸ் ,

Anne Beal joins GlaxoSmithKline's board as a non-executive director


Anne Beal joins GlaxoSmithKline s board as a non-executive director
 
30 Apr 2021
Dr Anne Beal is joining GlaxoSmithKline s board as a non-executive director and member of the Corporate Responsibility Committee, which provides important oversight of the company’s Trust agenda including policies towards access to medicines, global health, inclusion and diversity and environmental sustainability.
She will succeed Lynn Elsenhans as chair of the Committee after the 2022 Annual General Meeting. Ms Elsenhans has agreed to remain on the board for a further year to facilitate an orderly transition to Anne s leadership of the Committee.
Anne will bring to GSK extensive healthcare experience as a physician and entrepreneur combined with a passion for patient advocacy. She is a recognised health policy expert in the development of global and national programmes for improving healthcare access for all patient groups and in ensuring the voice of patients is reflected in ....

Jonathan Symonds , Anne Beal , Lynn Elsenhans , Corporate Responsibility Committee , Sir Jonathan Symonds , ஜொனாதன் சைமண்ட்ஸ் , அன்னே பீல் , பெருநிறுவன பொறுப்பு குழு , ஐயா ஜொனாதன் சைமண்ட்ஸ் ,